Thymine DNA glycosylase as a novel target for melanoma

Melanoma is an aggressive neoplasm with increasing incidence that is classified by the NCI as a recalcitrant cancer, i.e., a cancer with poor prognosis, lacking progress in diagnosis and treatment. In addition to conventional therapy, melanoma treatment is currently based on targeting the BRAF/MEK/E...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncogene
Autors principals: Mancuso, Pietro, Tricarico, Rossella, Bhattacharjee, Vikram, Cosentino, Laura, Kadariya, Yuwaraj, Jelinek, Jaroslav, Nicolas, Emmanuelle, Einarson, Margret, Beeharry, Neil, Devarajan, Karthik, Katz, Richard A., Dorjsuren, Dorjbal G., Sun, Hongmao, Simeonov, Anton, Giordano, Antonio, Testa, Joseph R., Davidson, Guillaume, Davidson, Irwin, Larue, Lionel, Sobol, Robert W., Yen, Timothy J., Bellacosa, Alfonso
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6563616/
https://ncbi.nlm.nih.gov/pubmed/30674989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0640-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars